Ilke Nalbantoglu, MD
Associate Professor of PathologyCards
About
Research
Publications
2026
Push pin induced artifact: A mimic of iron pill injury in gastrointestinal pathology
Olave M, Manrai P, Nalbantoglu I, Jain D, Barbieri A. Push pin induced artifact: A mimic of iron pill injury in gastrointestinal pathology. Human Pathology 2026, 173: 106119. PMID: 41967648, DOI: 10.1016/j.humpath.2026.106119.Peer-Reviewed Original ResearchTransdifferentiation in TSC2-Mutant Metastatic Pancreatic Neuroendocrine Tumor
Rodman C, Gibson J, Nalbantoglu I, Kunz P. Transdifferentiation in TSC2-Mutant Metastatic Pancreatic Neuroendocrine Tumor. JCO Precision Oncology 2026, 10: e2500663. PMID: 41494141, DOI: 10.1200/po-25-00663.Peer-Reviewed Original Research3.3 Small Bowel Disorders: Celiac Disease and Mimics
Nalbantoglu I, Jain D. 3.3 Small Bowel Disorders: Celiac Disease and Mimics. 2026, 197-207. DOI: 10.1016/b978-0-323-82688-4.00063-7.Peer-Reviewed Original Research
2025
Hepatic Granulomas and Granulomatous Hepatitis
Utku C, Nalbantoglu I. Hepatic Granulomas and Granulomatous Hepatitis. Practical Anatomic Pathology 2025, 109-126. DOI: 10.1007/978-3-031-97506-6_8.ChaptersWilson’s Disease
Nalbantoglu I. Wilson’s Disease. Practical Anatomic Pathology 2025, 31-40. DOI: 10.1007/978-3-031-97506-6_3.ChaptersMargin clearance and post‐procedure ablation decrease recurrence risk in endoscopic mucosal resections for Barrett's‐related neoplasia
Bell P, Kaul V, Bittner K, Chen I, Huber A, Sagan O, Chen W, Nalbantoglu I, Gonzalez R. Margin clearance and post‐procedure ablation decrease recurrence risk in endoscopic mucosal resections for Barrett's‐related neoplasia. Histopathology 2025, 87: 856-868. PMID: 40964766, DOI: 10.1111/his.15554.Peer-Reviewed Original ResearchPatterns of sialyl-Lewis X expression predict gastric histopathology
Vargas N, Quiroga A, Chaves J, Bolaños H, Nalbantoglu I, Astaiza C, Wu Y, Sáenz J. Patterns of sialyl-Lewis X expression predict gastric histopathology. Diagnostic Pathology 2025, 20: 76. PMID: 40551130, PMCID: PMC12183862, DOI: 10.1186/s13000-025-01673-8.Peer-Reviewed Original ResearchApobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancer
Blanc V, Riordan J, Soleymanjahi S, Nadeau J, Nalbantoglu I, Xie Y, Molitor E, Madison B, Brunt E, Mills J, Rubin D, Ng I, Ha Y, Roberts L, Davidson N. Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancer. Journal Of Clinical Investigation 2025, 135: e194717. PMID: 40454486, PMCID: PMC12126243, DOI: 10.1172/jci194717.Commentaries, Editorials and Letters
2024
Validation of Metallothionein Immunohistochemistry as a Highly Sensitive Screening Test for Wilson Disease
Stokes N, Patil A, Adeyi O, Bhalla A, Brown I, Byrnes K, Calderaro J, Chen D, Chen W, Cooper C, Dhall D, Frankel W, Gooch G, Gonzalez R, Hammer S, Hale G, Lagana S, McKenzie C, Allende D, Moreira R, Nakhleh R, Nalbantoglu I, Pai R, Salomao M, Schaeffer D, Shih A, Shin J, Simoes C, Vij M, Rela M, Xue Y, Yantiss R, Sabatto B, Graham R. Validation of Metallothionein Immunohistochemistry as a Highly Sensitive Screening Test for Wilson Disease. Modern Pathology 2024, 38: 100628. PMID: 39384020, DOI: 10.1016/j.modpat.2024.100628.Peer-Reviewed Original ResearchValidation of a whole slide image management system for metabolic‐associated steatohepatitis for clinical trials
Pulaski H, Mehta S, Manigat L, Kaufman S, Hou H, Nalbantoglu I, Zhang X, Curl E, Taliano R, Kim T, Torbenson M, Glickman J, Resnick M, Patel N, Taylor C, Bedossa P, Montalto M, Beck A, Wack K. Validation of a whole slide image management system for metabolic‐associated steatohepatitis for clinical trials. The Journal Of Pathology Clinical Research 2024, 10: e12395. PMID: 39294925, PMCID: PMC11410674, DOI: 10.1002/2056-4538.12395.Peer-Reviewed Original Research
Clinical Trials
Current Trials
Wilson Disease Registry
IRB ID1609018429REGRoleSub InvestigatorPrimary Completion Date10/01/2022Recruiting ParticipantsGenderBoth
Clinical Care
Overview
ILKe Nalbantoglu, MD, is a pathologist who specializes in surgical pathology as well as gastrointestinal and liver pathology. She focuses on diagnosing a wide range of diseases by examining tissues and organs related to the digestive tract and liver. Her detailed tissue evaluations help guide treatment decisions in collaboration with other health care professionals.
As an associate professor of pathology at Yale School of Medicine, Dr. Nalbantoglu is involved in clinical and translational research that advances the understanding of disease processes at the cellular level, which contributes to the development of more effective diagnostic techniques. Her main areas of interest are inflammatory diseases of the liver, liver transplant pathology, and unusual inflammatory disorders of the intestine. Her academic role also includes teaching and training the next generation of pathologists. Dr. Nalbantoglu lectures on GI- and liver-related topics nationally and internationally.
Dr. Nalbantoglu received her medical training from Ege University School of Medicine in Turkey, followed by a residency in anatomic and clinical pathology in St. John’s Hospital and Medical Center, and a fellowship in Liver/GI pathology at Emory University.
Board Certifications
Anatomic & Clinical Pathology
- Certification Organization
- AB of Pathology
- Latest Certification Date
- 2020
- Original Certification Date
- 2009